Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 Next Page Last Page
 
1
Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
2008-11-24

Antagonism of the adenosine A(2a) receptor offers great promise in the treatment of Parkinson's disease. In the course of exploring pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A(2A) antagonists, which led to clinical candidate ...

PubMed

2
Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
2008-06-04

Adenosine A(2A) and dopamine D(2) receptors (A(2A) and D(2)) associate in homo- and heteromeric complexes in the striatum, providing a structural basis for their mutual antagonism. At the cellular level, the portion of ...

PubMed

3
Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine.
2008-02-08

The excitatory action of brain-derived neurotrophic factor (BDNF) on synaptic transmission is triggered by adenosine A2A receptor activation. Since high-frequency neuronal firing, such as that inducing long-term potentiation (LTP), favours both A2A ...

PubMed

4
DARPP Chocolate: A Caffeinated Morsel of Striatal Signaling
2003-01-14

The psychomotor stimulant effects of caffeine, the most widely consumed psychoactive substance, are mediated through its antagonism of extracellular adenosine receptors in the basal ganglia. In the absence of caffeine, adenosine stimulates inhibitory striatopallidal neurons that suppress motor activity by binding to A2A receptors, ...

NSDL National Science Digital Library

5
Low Ethanol Sensitivity and Increased Ethanol Consumption in Mice Lacking Adenosine A2A Receptors

Low Ethanol Sensitivity and Increased Ethanol Consumption in Mice Lacking Adenosine A2A Receptors2AR / ) mice. In the present report, we further characterize the role of adenosine A2A receptors be- tween the two genotypes. The ...

E-print Network

6
Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
2011-03-01

Adenosine A(2A) receptor antagonists are one of the most attractive classes of drug for the treatment of Parkinson's disease (PD) as they are effective in counteracting motor dysfunctions and display neuroprotective and anti-inflammatory effects in animal models of PD. In this study, we evaluated the ...

PubMed

7
Caffeine, adenosine receptors, and synaptic plasticity.
2010-01-01

Few studies to date have looked at the effects of caffeine on synaptic plasticity, and those that did used very high concentrations of caffeine, whereas the brain concentrations attained by regular coffee consumption in humans should be in the low micromolar range, where caffeine exerts pharmacological actions mainly by antagonizing adenosine receptors. ...

PubMed

8
ADENOSINE NEGATIVELY REGULATES DUODENAL MOTILITY IN MICE: ROLE OF A(1) AND A(2A) RECEPTORS.
2011-05-26

Background and purpose. This study was undertaken to investigate the role of adenosine in the modulation of the contractility in mouse duodenum and to characterize the adenosine receptor subtypes involved. Experimental approach. RT-PCR was used to investigate the expression of mRNA encoding for A(1) , A(2A) , A(2B) ...

PubMed

9
Novel 8-(furan-2-yl)-3-benzyl thiazolo [5,4-e][1,2,4] triazolo [1,5-c] pyrimidine-2(3H)-thione as selective adenosine A(2A) receptor antagonist.
2010-08-11

Adenosine A(2A) receptor (A(2A)R) antagonists have emerged as potential drug candidates to alleviate progression and symptoms of Parkinson's disease (PD), and reduce the dopaminergic side effects. The synthesis of novel compound 8-(furan-2-yl)-3-benzyl ...

PubMed

10
Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism.
2011-01-14

The antagonism or genetic deletion of adenosine A(2A) receptors has been shown to exacerbate tissue damage in acute lung injury. Caffeine, a widely consumed behavioral drug, acts as a non-selective antagonist of A(2A) receptor and also has additional pharmacological ...

PubMed

11
Cocaine exposure modulates dopamine and adenosine signaling in the fetal brain
2009-09-16

Exposure to cocaine during the fetal period can produce significant lasting changes in the structure and function of the brain. Cocaine exerts its effects on the developing brain by blocking monoamine transporters and impairing monoamine receptor signaling. Dopamine is a major central target of cocaine. In a mouse model, we show that cocaine exposure from embryonic day 8 (E8) ...

PubMed Central

12
The distinct role of medium spiny neurons and cholinergic interneurons in the D?/A?A receptor interaction in the striatum: implications for Parkinson's disease.
2011-02-01

A(2A) adenosine receptor antagonists are currently under investigation as potential therapeutic agents for Parkinson's disease (PD). However, the molecular mechanisms underlying this therapeutic effect is still unclear. A functional antagonism exists between ...

PubMed

13
Adenosine receptor regulation of coronary blood flow in Ossabaw miniature swine.
2010-09-20

Adenosine clearly regulates coronary blood flow (CBF); however, contributions of specific adenosine receptor (AR) subtypes (A(1), A(2A), A(2B), A(3)) to CBF in swine have not been determined. ARs generally decrease (A(1), A(3)) or increase (A(2A), ...

PubMed

14
mGlu5 and adenosine A2A receptor interactions regulate the conditioned effects of cocaine.
2011-08-01

Adenosine A2A receptors and metabotropic glutamate type 5 (mGlu5) receptors are co-localized in the striatum and can functionally interact to regulate drug-seeking. We further explored this interaction using antagonism of mGlu5 receptors with ...

PubMed

15
Targeting Adenosine A2A Receptors in Parkinson's Disease.
2006-01-01

In pursuit of an improved understanding and treatment of Parkinson's disease (PD) and related neuropsychiatric disease we have held a translational research conference entitled, 'Targeting Adenosine A2A Receptors in Parkinson's Disease and other CNS Disor...

National Technical Information Service (NTIS)

16
Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors - Figure 6: On the physiological role of antagonistic intramembrane A2A��D2 receptor interactions potentially existing in putative A2A��D2 heterodimers
2008-12-01

Figure 6: On the physiological role of antagonistic intramembrane A2A��D2 receptor interactions potentially existing in putative A2A��D2 heterodimers. Legend: A: illustration of the antagonistic intramembrane ...

NSDL National Science Digital Library

17
Adenosine A2A receptors in both bone marrow cells and non-bone marrow cells contribute to traumatic brain injury.
2010-03-29

Adenosine A2A receptors (A(2A)Rs) in bone marrow-derived cells (BMDCs) are involved in regulation of inflammation and outcome in several CNS injuries; however their relative contribution to traumatic brain injury (TBI) is unknown. In this study, we ...

PubMed

18
Adenosine can mediate its actions through generation of reactive oxygen species.
2010-06-09

Adenosine is an important cerebral vasodilator, but mediating mechanisms are not understood. We investigated the expression of adenosine receptor subtypes in isolated cerebral arterial muscle cells (CAMCs), and their role in adenosine-induced superoxide (O(2)(-)) generation and reduction in cerebral arterial tone. Reverse transcriptase-PCR, western blotting, and ...

PubMed

19
Methylxanthines, inflammation, and cancer: fundamental mechanisms.
2011-01-01

Methylxanthines are an integral part of everyday food and drink consumption even though the majority of humans do not identify them by their chemical name. The breakthrough in understanding the action(s) of methylxanthines was in large part due to the understanding that methylxanthines can function as antagonists of adenosine receptors. This represented an example of ...

PubMed

20
Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease.
2011-08-16

Huntington disease (HD) is a neurodegenerative disorder involving preferential loss of striatal GABAergic medium spiny neurons. Adenosine A(2A) receptors (A(2A)Rs) are present in the striatum at both presynaptic and post-synaptic levels. Blocking ...

PubMed

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
21
Targeting Adenosine A2A Receptors in Parkinson's Disease
2006-11-01

... modify the affinity for the hormone or ligand ... intake, suggesting that female hormones may prevent the ... that treatment with A2A antagonists may be a ...

DTIC Science & Technology

22
Targeting Adenosine A2A Receptors in Parkinson's Disease
2006-11-01

... PARKINSONS DISEASE, SYMPOSIA, ADENOSINE, STROKES(CEREBRAL), CLINICAL TRIALS, ALZHEIMER DISEASE, MENTAL DISORDERS ...

DTIC Science & Technology

23
Adenosine A(2A) Receptor Binding Profile of Two Antagonists, ST1535 and KW6002: Consideration on the Presence of Atypical Adenosine A(2A) Binding Sites.
2010-08-06

Adenosine A(2A) receptors seem to exist in typical (more in striatum) and atypical (more in hippocampus and cortex) subtypes. In the present study, we investigated the affinity of two adenosine A(2A) receptor antagonists, ST1535 [2 ...

PubMed

24
Translating Adenosine A24 Receptor Biology into Novel Therapies for Parkinson's Disease.
2002-01-01

Recent advances in the pharmacology, neurotoxicology and epidemiology of the adenosine A2A receptor have provided evidence that A2A receptor antagonists (including caffeine) may offer therapeutic benefits in Parkinson's disease (PD) at multiple levels. No...

National Technical Information Service (NTIS)

25
Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors.
2006-06-21

Motor nerve terminals possess adenosine A(2A) receptors and brain derived neurotrophic factor (BDNF) TrkB receptors. In the present work we evaluated how BDNF actions on neuromuscular transmission would be influenced by adenosine ...

PubMed

26
Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors.
2007-01-01

We previously reported that adenosine, through A(2A) receptor activation, potentiates synaptic actions of brain-derived neurotrophic factor (BDNF) in the hippocampus of infant (3-4 weeks) rats. Since A(2A)-receptor-mediated actions are more evident in ...

PubMed

27
New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
2011-06-28

A series of 4-allyl/benzyl-7,8-dihydro-8-methyl/ethyl-2-[(substituted)isoxazol/pyrazol-3/5-yl]-1H-imidazo[2,1-i]purin-5(4H)-ones has been synthesized and evaluated in radioligand binding assays to determine their affinities at the human A(1), A(2A), and A(3) adenosine receptors. Efficacy at the hA(2B) AR and ...

PubMed

28
Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts.
2010-07-11

In this paper we review some novel aspects related to the way adenosine A(2A) receptors (A(2A)R) modulate the action of BDNF or its high-affinity receptors, the TrkB receptors, on synaptic transmission and ...

PubMed

29
Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors - Figure 5: Antagonistic A2A��D2 receptor interactions and an inhibitory allosteric modulator homocysteine may exist in the control of D2 receptor signaling in putative A2A��D2 heterodimers of the striatopallidal GABA neurons
2008-12-01

Figure 5: Antagonistic A2A��D2 receptor interactions and an inhibitory allosteric modulator homocysteine may exist in the control of D2 receptor signaling in putative A2A��D2 heterodimers of the striatopallidal GABA neurons. ...

NSDL National Science Digital Library

30
DRD2 Taq1A Polymorphism Modulates Prolactin Secretion Induced by Atypical Antipsychotics in Healthy Volunteers.
2011-10-01

Hyperprolactinemia mediated by antagonism of dopaminergic neurotransmission in the pituitary gland is a common adverse effect of antipsychotics. Recent studies have suggested that polymorphisms of dopamine receptors can affect the therapeutic response to antipsychotics. Thus, our aim was to evaluate whether 2 such polymorphisms (DRD2 Taq1A and DRD3 ...

PubMed

31
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.
2011-05-23

Syntheses and physicochemical properties of N-cycloalkyl-substituted imidazo-, pyrimido- and 1,3-diazepino[2,1-f]purinediones are described. These derivatives were synthesized by cyclization of 7-halogenoalkyl-8-bromo-1,3-dimethylxanthine derivatives with aminocycloalkanes. The obtained compounds (1-33) were evaluated for their affinity to rat adenosine A(1) and A(2A) ...

PubMed

32
Trapping Small Caffeine in a Large GPCR Pocket.
2011-09-01

Three new X-ray structures of a thermostabilized A(2A) adenosine receptor in complex with different antagonists reported by Dor� et�al. in this issue have advanced the understanding of molecular recognition for this receptor. PMID:21893281

PubMed

33
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
2008-03-30

The (-)-(11R,2'S)-enantiomer of the antimalarial drug mefloquine has been found to be a reasonably potent and moderately selective adenosine A(2A) receptor antagonist. Further investigation of this compound has led to the discovery of a series of keto-aryl thieno[3,2-d]pyrimidine derivatives, which are potent and ...

PubMed

34
Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens.
2011-07-01

Caffeine, the most widely used psychoactive compound, is an adenosine receptor antagonist. It promotes wakefulness by blocking adenosine A(2A) receptors (A(2A)Rs) in the brain, but the specific neurons on which caffeine acts to ...

PubMed

35
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
2010-03-07

Two reactive metabolites were identified in vivo for the dual A(2A)/A(1) receptor antagonist 1. Two strategies were implemented to successfully mitigate the metabolic liabilities associated with 1. Optimization of the arylindenopyrimidines led to a number of amide, ether, and amino analogs having comparable in ...

PubMed

36
A2A receptors in inflammation and injury: lessons learned from transgenic animals.
2007-12-26

Adenosine regulates the function of the innate and adaptive immune systems through targeting virtually every cell type that is involved in orchestrating an immune/inflammatory response. Of the four adenosine receptors (A(1), A(2A), A(2B), A(3)), A(2A) ...

PubMed

37
Adenosine receptor-adenylate cyclase system in the trout testis: involvement in the regulation of germ cell proliferation.
2001-03-01

To ascertain the presence of adenosine receptors in the trout testis, cells isolated from testes at different spermatogenetic stages were cultured in the presence or absence of adenosine, adenosine receptor agonists, or antagonists and of cAMP analogs, for up to 20 min, or 20 hr, or 4.5 days. Cyclic AMP production was then assayed or 3H-thymidine ...

PubMed

38
Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
2010-11-04

Several recent studies suggest functional and molecular interactions between striatal adenosine A(2A) and cannabinoid CB(1) receptors. Here, we demonstrate that A(2A) receptors selectively modulate reinforcing effects of cannabinoids. We studied effects of A(2A) receptor ...

PubMed

39
Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders.
2010-07-23

Parkinson's Disease (PD) and Extrapyramidal Syndrome (EPS) are movement disorders that result from degeneration of the dopaminergic input to the striatum and chronic inhibition of striatal dopamine D(2) receptors by antipsychotics, respectively. Adenosine A(2A) receptors are selectively ...

PubMed

40
Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors - Figure 4: Electrostatic epitope-epitope interactions represent important parts of the receptor interface between A2A-D2 heterodimers
2008-12-01

Figure 4: Electrostatic epitope-epitope interactions represent important parts of the receptor interface between A2A-D2 heterodimers. Legend: Electrostatic epitope-epitope interactions represent important parts of the receptor interface between ...

NSDL National Science Digital Library

First Page Previous Page 1 2 3 Next Page Last Page
 
First Page Previous Page 1 2 3 Next Page Last Page
 
41
Crosstalk between adenosine receptor (A2A isoform) and ERalpha mediates ethanol action in MCF-7 breast cancer cells.
2009-04-01

Alcohol consumption increases the risk of breast cancer but the underlying mechanisms are not well understood. We have shown previously that ethanol activates ER signalling pathway in a cAMP/PKA-mediated ligand-independent manner. Since the activation of A2A adenosine receptor (A2AAR) by ethanol has been reported in other cell types, here we tested if cross-talk between this ...

PubMed

42
2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.
2011-05-27

Rat vascular smooth muscle cells (VSMCs) from renal microvessels metabolize 2',3'-cAMP to 2'-AMP and 3'-AMP, and these AMPs are converted to adenosine that inhibits microvascular VSMC proliferation via A(2B) receptors. The goal of this study was to test whether this mechanism also exists in VSMCs from conduit arteries and whether it is similarly expressed in human vs. rat ...

PubMed

43
The Kappa Opioid Agonist U-50, 488H Antagonizes ...

... Title : The Kappa Opioid Agonist U-50, 488H Antagonizes Respiratory Effects of Mu Opioid Receptor Agonists in Conscious Rats. ...

DTIC Science & Technology

44
Adenosine A(2A) receptor in the monkey basal ganglia: Ultrastructural localization and co-localization with the metabotropic glutamate receptor 5 in the striatum.
2011-08-19

The adenosine A(2A) receptor (A(2A) R) is a potential drug target for the treatment of Parkinson's Disease and other neurological disorders. In rodents, the therapeutic efficacy of A(2A) R modulation is improved by concomitant modulation of the ...

PubMed

45
Structural features of adenosine receptors: from crystal to function.
2010-06-02

The important role that extracellular adenosine plays in many physiological processes is mediated by the adenosine class of G protein-coupled receptors, a class of receptors that also responds to the antagonist caffeine, the most widely used pharmacological agent in the world. The crystallographic model of the human adenosine ...

PubMed

First Page Previous Page 1 2 3 Next Page Last Page